Proposed Data Collections Submitted for Public Comment and Recommendations, 55496-55497 [2014-22010]
Download as PDF
55496
Federal Register / Vol. 79, No. 179 / Tuesday, September 16, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Sentinel Family Cohort .....................
Sentinel Family Cohort .....................
Cohort Intake ....................................
Cohort Weekly Illness Reporting .....
360
360
1
12
10/60
3/60
60
216
Total ...........................................
...........................................................
........................
........................
........................
1,109
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–22009 Filed 9–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–0740]
tkelley on DSK3SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 and
send comments to Leroy A. Richardson,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to omb@
cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
VerDate Sep<11>2014
18:22 Sep 15, 2014
Jkt 232001
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Medical Monitoring Project (MMP)—
(OMB No. 0920–0740, Expiration: 5/31/
2015)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of HIV/AIDS
Prevention (DHAP) requests a revision
of the currently approved Information
Collection Request: ‘‘Medical
Monitoring Project’’ expiring May 31,
2015. This data collection addresses the
need for national estimates of access to
and utilization of HIV-related medical
care and services, the quality of HIVrelated ambulatory care, and HIVrelated behaviors and clinical outcomes.
For the proposed project, the same
data collection methods will be used as
for the currently approved project. Data
would be collected from a probability
sample of HIV-diagnosed adults in the
U.S. who consent to an interview and
abstraction of their medical records. As
for the currently approved project, deidentified information would also be
extracted from HIV case surveillance
records for a dataset, referred to as the
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
minimum dataset, which is used to
assess non-response bias, for quality
control, to improve the ability of MMP
to monitor ongoing care and treatment
of HIV-infected persons, and to make
inferences from the MMP sample to
HIV-diagnosed persons nationally. No
other Federal agency collects such
nationally representative populationbased information from HIV-diagnosed
adults. The data are expected to have
significant implications for policy,
program development, and resource
allocation at the state/local and national
levels.
The changes proposed in this request
update the data collection system to
meet prevailing information needs and
enhance the value of MMP data, while
remaining within the scope of the
currently approved project purpose. The
result is a 16% reduction in burden, or
a reduction of 1,397 total burden hours
annually.
A change in sampling methods
accounts for the net reduction in
burden. Specifically, sampling from the
existing HIV case surveillance database,
the National HIV Surveillance System
(NHSS, OMB Control No. 0920–0573,
Exp. 2/29/2016) would replace the
current health care-facility-based
sampling. This change in sampling
methods would broaden participation in
MMP to all HIV-infected persons who
have been diagnosed and reported to the
NHSS, a population that is more
representative of persons living with
HIV than are persons receiving HIV
medical care. Sampling from NHSS will
allow MMP to address key information
gaps related to increasing access to care,
one of three strategic areas of national
focus of the National HIV/AIDS
Strategy.
The change in project sampling
methods reduces the amount of time
health care facility staff will spend on
project activities, substantially reducing
burden hours and offsetting increases in
burden from other changes, listed
below.
Restoration of the original sample of
26 geographic primary sampling units is
proposed in this request, for more
complete coverage of the population of
E:\FR\FM\16SEN1.SGM
16SEN1
55497
Federal Register / Vol. 79, No. 179 / Tuesday, September 16, 2014 / Notices
interest. Three project areas that
initially participated in MMP—and
were subsequently dropped in 2009
because funding was restricted—will be
reinstated as primary sampling units if
funding allows.
Increasing the sample size in three
areas that were previously allocated
comparatively small samples (Georgia,
Illinois, and Pennsylvania) is expected
to improve the ability to produce
representative local estimates in these
areas.
Health care facility staff may be asked
to look up contact information for
sampled persons with incomplete or
incorrect contact information in NHSS;
this was not necessary in prior MMP
cycles because the patient samples were
drawn from facility records.
Finally, changes were made that did
not affect the burden, listed below:
• The interview instrument was
revised to enable the collection of
critical information from HIV-infected
persons not receiving medical care and
to improve question coherence, boost
the efficiency of the data collection, and
increase the relevance and value of the
in the interview and facilitate
communication between respondent
and interviewer, for example, by
allowing interviewers to respond
appropriately to a respondent’s visual
cues. Videoconferencing will also allow
the interviewer to ensure that the
respondent is using the correct response
cards for interview questions. No audio/
audiovisual recordings will be made of
the interviews, including interviews
administered by videoconferencing.
This proposed data collection would
supplement the National HIV
Surveillance System (NHSS, OMB
Control No. 0920–0573, Exp. 2/29/2016)
in 26 selected state and local health
departments, which collect information
on persons diagnosed with, living with,
and dying from HIV infection and AIDS.
The participation of respondents is
voluntary. There is no cost to the
respondents other than their time.
Through their participation,
respondents will help to improve
programs to prevent HIV infection as
well as services for those who already
have HIV.
information. These changes were based
on an evaluation of the currently
approved MMP interview instrument
involving stakeholders, as well as a pilot
which evaluated new questions
(Formative Research and Tool
Development, OMB Control No. 0920–
0840, expiration 2/29/2016). These
revisions did not change the average
time required to complete the interview.
• Six data elements were removed
from the medical record abstraction
form and two data elements were added.
Because the medical records are
abstracted by MMP staff, these changes
do not affect the burden of the project
on the public.
• Sampled persons may be
interviewed wherever they currently
reside, conditional on local law and
policy, and in a manner specified by a
written, project-specific agreement with
the HIV surveillance unit at the person’s
local health department.
• Videoconferencing was added as an
optional mode of interview
administration. Administering the
interview via videoconferencing will
provide more flexibility for participating
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average hours
per response
(in hours)
8,720
2,180
1
1
45/60
2/60
6,540
73
...............................................
1,090
1
5/60
91
...............................................
8,720
1
3/60
436
...............................................
........................
........................
........................
7,140
Number of
respondents
Type of respondent
Form name
Sampled, Eligible HIV-Infected Persons ......
Facility office staff looking up contact information.
Facility office staff approaching sampled
persons for enrollment.
Facility office staff pulling medical records ...
Interview Questionnaire ........
...............................................
Total .......................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–22010 Filed 9–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
[Docket No. FDA–2014–D–1288]
Draft Guidance for Industry: Electronic
Submission of Lot Distribution
Reports; Availability; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
18:22 Sep 15, 2014
Lori
J. Churchyard, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301,
Silver Spring, MD 20993–0002, 240–
402–7911.
In the
Federal Register of Friday, August 29,
SUPPLEMENTARY INFORMATION:
Notice; correction.
VerDate Sep<11>2014
The Food and Drug
Administration is correcting a notice
entitled ‘‘Draft Guidance for Industry:
Electronic Submission of Lot
Distribution Reports; Availability’’ that
appeared in the Federal Register of
August 29, 2014 (79 FR 51576). The
document announced the availability of
a draft guidance entitled ‘‘Guidance for
Industry: Electronic Submission of Lot
Distribution Reports’’ dated August
2014. The document was published
with the incorrect docket number. This
document corrects that error.
SUMMARY:
Jkt 232001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Total
burden
hours
2014, in FR Doc. 2014–20635, on page
51576, the following correction is made:
1. On page 51576, in the first column,
in the Docket No. heading, ‘‘[FDA–
2014–S–0009]’’ is corrected to read
‘‘[FDA–2014–D–1288]’’.
Dated: September 10, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–22015 Filed 9–15–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Neurotransporters,
Receptors, and Calcium Signaling Study
E:\FR\FM\16SEN1.SGM
16SEN1
Agencies
[Federal Register Volume 79, Number 179 (Tuesday, September 16, 2014)]
[Notices]
[Pages 55496-55497]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22010]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-0740]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 and send comments to
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Medical Monitoring Project (MMP)--(OMB No. 0920-0740, Expiration:
5/31/2015)--Revision--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), Division of
HIV/AIDS Prevention (DHAP) requests a revision of the currently
approved Information Collection Request: ``Medical Monitoring Project''
expiring May 31, 2015. This data collection addresses the need for
national estimates of access to and utilization of HIV-related medical
care and services, the quality of HIV-related ambulatory care, and HIV-
related behaviors and clinical outcomes.
For the proposed project, the same data collection methods will be
used as for the currently approved project. Data would be collected
from a probability sample of HIV-diagnosed adults in the U.S. who
consent to an interview and abstraction of their medical records. As
for the currently approved project, de-identified information would
also be extracted from HIV case surveillance records for a dataset,
referred to as the minimum dataset, which is used to assess non-
response bias, for quality control, to improve the ability of MMP to
monitor ongoing care and treatment of HIV-infected persons, and to make
inferences from the MMP sample to HIV-diagnosed persons nationally. No
other Federal agency collects such nationally representative
population-based information from HIV-diagnosed adults. The data are
expected to have significant implications for policy, program
development, and resource allocation at the state/local and national
levels.
The changes proposed in this request update the data collection
system to meet prevailing information needs and enhance the value of
MMP data, while remaining within the scope of the currently approved
project purpose. The result is a 16% reduction in burden, or a
reduction of 1,397 total burden hours annually.
A change in sampling methods accounts for the net reduction in
burden. Specifically, sampling from the existing HIV case surveillance
database, the National HIV Surveillance System (NHSS, OMB Control No.
0920-0573, Exp. 2/29/2016) would replace the current health care-
facility-based sampling. This change in sampling methods would broaden
participation in MMP to all HIV-infected persons who have been
diagnosed and reported to the NHSS, a population that is more
representative of persons living with HIV than are persons receiving
HIV medical care. Sampling from NHSS will allow MMP to address key
information gaps related to increasing access to care, one of three
strategic areas of national focus of the National HIV/AIDS Strategy.
The change in project sampling methods reduces the amount of time
health care facility staff will spend on project activities,
substantially reducing burden hours and offsetting increases in burden
from other changes, listed below.
Restoration of the original sample of 26 geographic primary
sampling units is proposed in this request, for more complete coverage
of the population of
[[Page 55497]]
interest. Three project areas that initially participated in MMP--and
were subsequently dropped in 2009 because funding was restricted--will
be reinstated as primary sampling units if funding allows.
Increasing the sample size in three areas that were previously
allocated comparatively small samples (Georgia, Illinois, and
Pennsylvania) is expected to improve the ability to produce
representative local estimates in these areas.
Health care facility staff may be asked to look up contact
information for sampled persons with incomplete or incorrect contact
information in NHSS; this was not necessary in prior MMP cycles because
the patient samples were drawn from facility records.
Finally, changes were made that did not affect the burden, listed
below:
The interview instrument was revised to enable the
collection of critical information from HIV-infected persons not
receiving medical care and to improve question coherence, boost the
efficiency of the data collection, and increase the relevance and value
of the information. These changes were based on an evaluation of the
currently approved MMP interview instrument involving stakeholders, as
well as a pilot which evaluated new questions (Formative Research and
Tool Development, OMB Control No. 0920-0840, expiration 2/29/2016).
These revisions did not change the average time required to complete
the interview.
Six data elements were removed from the medical record
abstraction form and two data elements were added. Because the medical
records are abstracted by MMP staff, these changes do not affect the
burden of the project on the public.
Sampled persons may be interviewed wherever they currently
reside, conditional on local law and policy, and in a manner specified
by a written, project-specific agreement with the HIV surveillance unit
at the person's local health department.
Videoconferencing was added as an optional mode of
interview administration. Administering the interview via
videoconferencing will provide more flexibility for participating in
the interview and facilitate communication between respondent and
interviewer, for example, by allowing interviewers to respond
appropriately to a respondent's visual cues. Videoconferencing will
also allow the interviewer to ensure that the respondent is using the
correct response cards for interview questions. No audio/audiovisual
recordings will be made of the interviews, including interviews
administered by videoconferencing.
This proposed data collection would supplement the National HIV
Surveillance System (NHSS, OMB Control No. 0920-0573, Exp. 2/29/2016)
in 26 selected state and local health departments, which collect
information on persons diagnosed with, living with, and dying from HIV
infection and AIDS.
The participation of respondents is voluntary. There is no cost to
the respondents other than their time. Through their participation,
respondents will help to improve programs to prevent HIV infection as
well as services for those who already have HIV.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average hours
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Sampled, Eligible HIV-Infected Interview 8,720 1 45/60 6,540
Persons. Questionnaire.
Facility office staff looking ................ 2,180 1 2/60 73
up contact information.
Facility office staff ................ 1,090 1 5/60 91
approaching sampled persons
for enrollment.
Facility office staff pulling ................ 8,720 1 3/60 436
medical records.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 7,140
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-22010 Filed 9-15-14; 8:45 am]
BILLING CODE 4163-18-P